Key result
Pharmacy-conducted admission medication histories linked to ~27% fewer 30-day readmissions in high-risk patients vs standard care.
Why the study?
Thorough admission medication histories may prevent adverse drug events causing excess hospitalizations, but require scarce resources. The study evaluated if an electronic risk-scoring tool to target pharmacy-conducted admission medication histories reduces 30-day readmissions.
Does a pharmacy-conducted admission medication history targeted by a risk model reduce 30-day hospital readmissions in Medicine/Surgery patients?
Cohort (n=8,054)
No
Does a pharmacy-conducted admission medication history targeted by a risk model reduce 30-day hospital readmissions in Medicine/Surgery patients?
Absolute Event Rate: 11% vs 15%
p-value: p=0.004
Using an EMR-embedded risk tool to target pharmacy-conducted admission medication histories significantly reduces 30-day readmissions in high-risk patients.
Background: Adverse drug events (ADEs) result in excess hospitalizations. Thorough admission medication histories (AMHs) may prevent ADEs; however, the resources required oftentimes outweigh what is available in large hospital settings. Previous risk prediction models embedded into the Electronic Medical Record (EMR) have been used at hospitals to aid in targeting delivery of scarce resources. Objective: To determine if an AMH scoring tool used to allocate resources can decrease 30-day hospital readmissions. Design, Setting, and Participants: Propensity-matched cohort study, Medicine/Surgery patients in large academic safety-net hospital. Intervention or Exposure: Pharmacy-conducted AMHs identified by risk model versus standard of care AMH. Main Outcomes and Measures: A total of 30-day hospital readmissions and inpatient ADE prevention. Results: The model screened 87 240 hospitalizations between June 2017 and June 2019 and 4027 patients per group were included. There were significantly less 30 day readmissions among high-risk identified patients that received a pharmacy-conducted AMH compared to controls (11% vs 15%; P = 0.004) and no significant difference in readmission rates for low-risk patients. While there was significantly higher documentation of major ADE prevention in the pharmacy-led AMH group versus control (1656 vs 12; P < 0.001), there was no difference in electronically-detected inpatient ADEs between groups. Conclusions: A risk tool embedded into the EMR can be used to identify patients whom pharmacy teams can easily target for AMHs. This study showed significant reductions in readmissions for patients identified as high-risk. However, the same benefit in readmissions was not seen in those identified at low-risk, which supports allocating resources to those that will benefit the most.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2020) conducted a cohort in Medicine/Surgery patients (n=8,054). Pharmacy-conducted admission medication histories (AMHs) vs. Standard of care AMH was evaluated on 30-day hospital readmissions among high-risk patients (p=0.004). Pharmacy-conducted admission medication histories for high-risk patients significantly reduced 30-day hospital readmissions compared to standard of care (11% vs 15%; P=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: